| Title: |
MR-Guided Radiotherapy for Prostate Cancer. |
| Authors: |
Tocco, Boris R., Kishan, Amar U., Ma, Ting Martin, Kerkmeijer, Linda G. W., Tree, Alison C. |
| Source: |
Frontiers in Oncology; 12/9/2020, Vol. 10, pN.PAG-N.PAG, 11p |
| Subject Terms: |
PROSTATE cancer, CANCER radiotherapy, IMAGE-guided radiation therapy, DOSE fractionation |
| Abstract: |
External beam radiotherapy remains the primary treatment modality for localized prostate cancer. The radiobiology of prostate carcinoma lends itself to hypofractionation, with recent studies showing good outcomes with shorter treatment schedules. However, the ability to accurately deliver hypofractionated treatment is limited by current image-guided techniques. Magnetic resonance imaging is the main diagnostic tool for localized prostate cancer and its use in the therapeutic setting offers anatomical information to improve organ delineation. MR-guided radiotherapy, with daily re-planning, has shown early promise in the accurate delivery of radiotherapy. In this article, we discuss the shortcomings of current image-guidance strategies and the potential benefits and limitations of MR-guided treatment for prostate cancer. We also recount present experiences of MR-linac workflow and the opportunities afforded by this technology. [ABSTRACT FROM AUTHOR] |
|
Copyright of Frontiers in Oncology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
